CompanyNasdaqCaesarea
IceCure Medical Ltd
IceCure Medical develops liquid-nitrogen-based cryoablation systems for tumor destruction in breast, kidney, bone, and lung cancer.
6-KNov 9Latest SEC filing
Form DJun 25$17M sold
October 2026
Sign inSign inIceCure Medical develops liquid-nitrogen-based cryoablation systems for tumor destruction in breast, kidney, bone, and lung cancer.